Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Cyclin B1 anticorps (pSer147)

CCNB1 Reactivité: Humain WB, IHC, ELISA, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7138431
  • Antigène Voir toutes Cyclin B1 (CCNB1) Anticorps
    Cyclin B1 (CCNB1)
    Épitope
    • 23
    • 23
    • 22
    • 16
    • 9
    • 8
    • 7
    • 7
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer147
    Reactivité
    • 201
    • 95
    • 62
    • 20
    • 16
    • 16
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 161
    • 47
    • 1
    Lapin
    Clonalité
    • 155
    • 54
    Polyclonal
    Conjugué
    • 110
    • 10
    • 7
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 6
    • 4
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Cet anticorp Cyclin B1 est non-conjugé
    Application
    • 139
    • 75
    • 56
    • 47
    • 40
    • 40
    • 39
    • 31
    • 30
    • 11
    • 11
    • 11
    • 10
    • 9
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
     Réactivité croisée
    Humain
    Purification
    Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
    Immunogène
    Peptide sequence around phosphorylation site of Serine 147 (A-F-S(p)-D-V) derived from Human Cyclin B1.
    Isotype
    IgG
    Top Product
    Discover our top product CCNB1 Anticorps primaire
  • Indications d'application
    WB:1:500-1:1000, IHC:1:50-1:100, IF:1:100-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Supplied at 1.0 mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    Cyclin B1 (CCNB1)
    Autre désignation
    CCNB1 (CCNB1 Produits)
    Synonymes
    anticorps ccnb, anticorps cycb, anticorps cb267, anticorps cycb1, anticorps wu:fa19g04, anticorps wu:fb16d01, anticorps wu:fb16e07, anticorps wu:fi21c01, anticorps ccnb1, anticorps MGC53596, anticorps CCNB, anticorps Ccnb1-rs1, anticorps Ccnb1-rs13, anticorps CycB1, anticorps Cycb-4, anticorps Cycb-5, anticorps Cycb1-rs1, anticorps cyclin B1, anticorps cyclin B1 S homeolog, anticorps ccnb1, anticorps ccnb1.2, anticorps ccnb1.S, anticorps CCNB1, anticorps Ccnb1, anticorps ccnb1.2.S
    Sujet

    Background: The protein encoded by Cyclin B1 is a regulatory protein involved in mitosis. The gene product complexes with p34(cdc2) to form the maturation-promoting factor (MPF). Two alternative transcripts have been found, a constitutively expressed transcript and a cell cycle-regulated transcript, that is expressed predominantly during G2/M phase. The different transcripts result from the use of alternate transcription initiation sites.

    Norbury, C. and Nurse, P. (1992) Annu. Rev. Biochem. 61, 441-470.
    Atherton-Fessler, S. et al. (1993) Mol. Cell. Biol. 13, 1675-1685.
    Galaktionov, K. et al. (1995) Genes Dev. 9, 1046-1058.

    Aliases: CCNB 1 antibody, CCNB antibody, ccnb1 antibody, CCNB1_HUMAN antibody, Cyclin B1 antibody, G2 mitotic specific cyclin B1 antibody, G2/mitotic-specific cyclin-B1 antibody

    UniProt
    P14635
    Pathways
    Cycle Cellulaire, AMPK Signaling, Mitotic G1-G1/S Phases, M Phase
Vous êtes ici: